Episode description
🚨 Hear Jaishankar Kutty, Ph.D. discuss the critical impact of PFAS phase-out on medical device manufacturing and then, 🎟️ RSVP to our January 2024 event for exclusive downloadable content.
We hope you find Jai's commentary to be an excellent summary of the topic! Our January presentation and panel, Exiting PFAS: A Strategic Blueprint for Medical Device Manufacturers, will go significantly deeper, providing proactive strategies to navigate this major shift.
A few quick takeaways from Jai's clip...
🔬 PFAS substances have significant ramifications on medical device and IVD manufacturing.
🇪🇺 The proposed EU reach restriction and 3M's decision to stop manufacturing PFAS substances have regulatory and supply chain implications.
🔍 Device manufacturers need to identify PFAS substances used in their products and find alternate materials.
⚖️ Regulatory assessments and potential legal ramifications should be considered in the process.
Again, for substantially more on this topic and exclusive content, RSVP for the brief presentation and panel at this link.
-
🎟️ RSVP for the Jan. 18th panel and access exclusive downloads.
📹 View and share this clip on LinkedIn.
📲 Follow RQM+ on LinkedIn.
📚 See on-demand content in our Knowledge Center.
📝 If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use our contact form.